🔥 Tuesday 16 September 2025 Tue, 16 Sept 2025

North Stawell Minerals (ASX – NSM) reports promising drilling results and a robust project pipeline at its North Stawell Gold Project, highlighting shallow, high-grade gold mineralisation analogous to the nearby Stawell Gold Mine.

Peak Rare Earths shareholders have overwhelmingly approved Shenghe Resources’ acquisition scheme, setting the stage for imminent court approval and a cash payout.

Peak Rare Earths Limited shareholders are set to vote on Shenghe Resources’ $195 million acquisition offer, which includes a 32% premium over recent share prices. Despite a higher unsolicited bid from GICP, the board recommends accepting Shenghe’s proposal.

Mad Paws Holdings has secured Foreign Investment Review Board approval for Rover Group’s full acquisition scheme, with the board unanimously recommending shareholder support.

Cobalt Blue Holdings has secured a crucial works approval for its Kwinana Cobalt Refinery, pushing Australia’s first dedicated cobalt processing plant closer to a final investment decision by the end of 2025.

Tivan Limited has raised $15 million through a strategic share placement led by ETFS Capital, positioning the company for key project acquisitions and development in fluorite and tungsten mining.

Tivan Limited has agreed to acquire full ownership of the Molyhil Tungsten-Molybdenum Project, positioning itself at the forefront of critical minerals development in Australia's Northern Territory. This strategic move complements its adjacent Sandover Fluorite Project, promising operational synergies and accelerated growth.

Metal Bank Limited has completed due diligence on Hastings Technology Metals' gold assets and is set to commence drilling at the Seven Leaders prospect, marking a key step in its Western Australian gold expansion strategy.

Nyrada Inc. has released compelling preclinical data showing its drug candidate Xolatryp protects mitochondrial function by reducing calcium overload in brain injury models, bolstering confidence ahead of its Phase IIa trial in acute myocardial infarction.

Falcon Metals has reported impressive high-grade gold intercepts at its Blue Moon prospect, confirming continuation of historic reef lines and securing a second drill rig to accelerate exploration.

Assetora Limited has locked in a $3 million private placement from CloudTech Group, aiming to strengthen its balance sheet and fuel expansion plans. The deal unfolds in two tranches, with key conditions tied to audited reports and ASX reinstatement.

Aguia Resources has updated its economic study for the Tres Estrades Rock Phosphate Project, reflecting a significant uplift in phosphate pricing and expanded production capacity that together enhance the project's financial outlook.

VBX Limited reports promising low-silica bauxite discoveries at East Kalumburu A near its flagship Wuudagu project, alongside key strategic appointments and ongoing drilling programs advancing the project towards a targeted DFS completion in early 2026.

Peninsula Energy has successfully produced its first batch of dried yellowcake uranium at the Lance Project in Wyoming, marking a major step toward becoming a fully independent uranium producer in the US.

Paladin Energy Ltd has launched a significant A$300 million underwritten equity raising to advance its Patterson Lake South uranium project and support the ramp-up of its Langer Heinrich Mine, reinforcing its position in the global uranium market.

DUG Technology has secured its first purchase order under a major multi-year deal with PETRONAS, nearly doubling the contract’s total value to over US$43 million. This milestone signals a significant ramp-up in DUG’s cloud-based geoscience services.

Global Uranium and Enrichment Limited reports promising uranium intercepts from ongoing drilling at its Pine Ridge Project, reinforcing its development potential in the Powder River Basin.

Brightstar Resources reports underground mining operations at its Laverton Hub are significantly ahead of schedule, targeting a +50% quarter-on-quarter production increase in the September quarter. The Fish Mine has turned cash flow positive, underpinning a robust growth outlook.

Ballymore Resources reports standout high-grade gold, silver, and copper results from its latest drilling at the Dittmer Gold Project, reinforcing confidence in the Duffer Lode’s continuity and prompting plans to extend underground exploration.

Orthocell’s nerve repair device Remplir is being adopted in Australia for nerve-sparing prostate cancer surgeries, aiming to reduce erectile dysfunction and urinary incontinence post-operation. This development could significantly expand Remplir’s market reach globally.

Medallion Metals has taken a crucial step forward by ordering a secondary ball mill to upgrade the Cosmic Boy Concentrator, underpinning its Sulphide Production Strategy and advancing its feasibility study toward a final investment decision.

Tesoro Gold has released an expanded and upgraded scoping study for its Ternera open pit project in Chile, revealing strong economics and a 1.82 million ounce gold resource. The study highlights a straightforward development path with low capital costs and excellent gold recoveries.

Race Oncology has uncovered that its anticancer drug bisantrene exists as three light-sensitive isomers, with only one showing potent activity. The company has filed patents to protect this active form, potentially extending its intellectual property rights until 2045.

Power Minerals Limited has reported the highest rare earth element grades to date from re-assayed drill samples at its Santa Anna Project in Brazil, significantly enhancing the project's resource potential.